Select Macrophage Noncoding RNAs of Interest in Cardiovascular Disease

키워드

참고문헌 (59)

1. Benjamin EJ, "Heart disease and stroke statistics-2019 update : a report from the American Heart Association", Circulation, 139, pp.e56~e528 (2019)
2. Roth GA, "Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015", J Am Coll Cardiol, 70, pp.1~25 (2017)
3. Kinoshita M, "Japan Atherosclerosis Society(JAS)guidelines for prevention of atherosclerotic cardiovascular diseases 2017", J Atheroscler Thromb, 25, pp.846~984 (2018)
4. Bobryshev YV, "Macrophages and their role in atherosclerosis : pathophysiology and transcriptome analysis", BioMed Res Int, 2016, pp.9582430~ (2016)
5. Otsuka F, "Natural progression of atherosclerosis from pathologic intimal thickening to late fibroatheroma in human coronary arteries : a pathology study", Atherosclerosis, 241, pp.772~782 (2015)
6. Dick SA, "Self-renewing resident cardiac macrophages limit adverse remodeling following myocardial infarction", Nat Immunol, 20, pp.29~39 (2019)
7. Lavine KJ, "Distinct macrophage lineages contribute to disparate patterns of cardiac recovery and remodeling in the neonatal and adult heart", Proc Natl Acad Sci U S A, 111, pp.16029~16034 (2014)
8. Wang L, "CXCL1-CXCR2 axis mediates angiotensin II-induced cardiac hypertrophy and remodelling through regulation of monocyte infiltration", Eur Heart J, 39, pp.1818~1831 (2018)
9. Fatica A, "Long non-coding RNAs : new players in cell differentiation and development", Nat Rev Genet, 15, pp.7~21 (2014)
10. Batista PJ, "Long noncoding RNAs : cellular address codes in development and disease", Cell, 152, pp.1298~1307 (2013)
11. Mizuno T, "A unique mechanism regulating gene expression : translational inhibition by a complementary RNA transcript(micRNA)", Proc Natl Acad Sci U S A, 81, pp.1966~1970 (1984)
12. De Paepe B, "How long noncoding RNAs enforce their will on mitochondrial activity : regulation of mitochondrial respiration, reactive oxygen species production, apoptosis, and metabolic reprogramming in cancer", Curr Genet, 64, pp.163~172 (2018)
13. Das S, "Diabetes mellitus-induced long noncoding RNA Dnm3os regulates macrophage functions and inflammation via nuclear mechanisms", Arterioscler Thromb Vasc Biol, 38, pp.1806~1820 (2018)
14. Engels BM, "Principles and effects of microRNA-mediated post-transcriptional gene regulation", Oncogene, 25, pp.6163~6169 (2006)
15. Zhu Y, "A SWI", SNF chromatin-remodeling complex acts in noncoding RNA-mediated transcriptional silencing, 2013, pp.49, 298~309
16. Moseley ML, "Bidirectional expression of CUG and CAG expansion transcripts and intranuclear polyglutamine inclusions in spinocerebellar ataxia type 8", Nat Genet, 38, pp.758~769 (2006)
17. Carrieri C, "Long non-coding antisense RNA controls Uchl1 translation through an embedded SINEB2 repeat", Nature, 491, pp.454~457 (2012)
18. Lorenzen JM, "Long noncoding RNAs in kidney and cardiovascular diseases", Nat Rev Nephrol, 12, pp.360~373 (2016)
19. Kim TK, "Widespread transcription at neuronal activity-regulated enhancers", Nature, 465, pp.182~187 (2010)
20. Ding M, "Enhancer RNAs(eRNAs) : new insights into gene transcription and disease treatment", J Cancer, 9, pp.2334~2340 (2018)
21. Ransohoff JD, "The functions and unique features of long intergenic non-coding RNA", Nat Rev Mol Cell Biol, 19, pp.143~157 (2018)
22. Klattenhoff CA, "Braveheart, a long noncoding RNA required for cardiovascular lineage commitment", Cell, 152, pp.570~583 (2013)
23. Zangrando J, "Identification of candidate long non-coding RNAs in response to myocardial infarction", BMC Genomics, 15, pp.460~ (2014)
24. Roy S, "MiRNA in innate immune responses : novel players in wound inflammation", Physiol Genomics, 43, pp.557~565 (2011)
25. O'Neill LA, "A guide to immunometabolism for immunologists", Nat Rev Immunol, 16, pp.553~565 (2016)
26. Bochenek G, "The large non-coding RNA ANRIL, which is associated with atherosclerosis, periodontitis and several forms of cancer, regulates ADIPOR1, VAMP3 and C11ORF10", Hum Mol Genet, 22, pp.4516~4527 (2013)
27. Holdt LM, "Circular non-coding RNA ANRIL modulates ribosomal RNA maturation and atherosclerosis in humans", Nat Commun, 7, pp.12429~ (2016)
28. Thomas AA, "ANRIL : a regulator of VEGF in diabetic retinopathy", Invest Ophthalmol Vis Sci, 58, pp.470~480 (2017)
29. Harismendy O, "9p21 DNA variants associated with coronary artery disease impair interferon-γ signalling response", Nature, 470, pp.264~268 (2011)
30. Zhou X, "Long non-coding RNA ANRIL regulates inflammatory responses as a novel component of NF-κB pathway", RNA Biol, 13, pp.98~108 (2016)
31. Kotake Y, "Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15INK4B tumor suppressor gene", Oncogene, 30, pp.1956~1962 (2011)
32. Dutta P, "Myocardial infarction activates CCR2+ hematopoietic stem and progenitor cells", Cell Stem Cell, 16, pp.477~487 (2015)
33. Janzen V, "Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a", Nature, 443, pp.421~426 (2006)
34. Li H, "Long non-coding RNA CDKN2B-AS1 reduces inflammatory response and promotes cholesterol efflux in atherosclerosis by inhibiting ADAM10 expression", Aging(Albany NY), 11, pp.1695~1715 (2019)
35. Zhou X, "Stage-dependent involvement of ADAM10 and its significance in epileptic seizures", J Cell Mol Med, 23, pp.4494~4504 (2019)
36. van der Vorst EP, "A disintegrin and metalloproteases(ADAMs)in cardiovascular, metabolic and inflammatory diseases : aspects for theranostic approaches", Thromb Haemost, 118, pp.1167~1175 (2018)
37. Pasmant E, "ANRIL, a long, noncoding RNA, is an unexpected major hotspot in GWAS", FASEB J, 25, pp.444~448 (2011)
38. Visel A, "Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice", Nature, 464, pp.409~412 (2010)
39. Sallam T, "Transcriptional regulation of macrophage cholesterol efflux and atherogenesis by a long noncoding RNA", Nat Med, 24, pp.304~312 (2018)
40. Sallam T, "Feedback modulation of cholesterol metabolism by the lipid-responsive non-coding RNA LeXis", Nature, 534, pp.124~128 (2016)
41. Zhang F, "Identification of the long noncoding RNA NEAT1 as a novel inflammatory regulator acting through MAPK pathway in human lupus", J Autoimmun, 75, pp.96~104 (2016)
42. Liu X, "Long non-coding RNA NEAT1-modulated abnormal lipolysis via ATGL drives hepatocellular carcinoma proliferation", Mol Cancer, 17, pp.90~ (2018)
43. Yong W, "Long noncoding RNA NEAT1, regulated by LIN28B, promotes cell proliferation and migration through sponging miR-506 in high-grade serous ovarian cancer", Cell Death Dis, 9, pp.861~ (2018)
44. Gast M, "Long noncoding RNA NEAT1 modulates immune cell functions and is suppressed in early onset myocardial infarction patients", Cardiovasc Res, 115, pp.1886~1906 (2019)
45. Wang L, "Blockade of NEAT1 represses inflammation response and lipid uptake via modulating miR-342-3p in human macrophages THP-1 cells", J Cell Physiol, 234, pp.5319~5326 (2019)
46. Chen DD, "NEAT1 contributes to ox-LDL-induced inflammation and oxidative stress in macrophages through inhibiting miR-128", J Cell Biochem, 120, pp.2493~2501 (2018)
47. Zhang P, "The lncRNA Neat1 promotes activation of inflammasomes in macrophages", Nat Commun, 10, pp.1495~ (2019)
48. Rayner KJ, "MiR-33 contributes to the regulation of cholesterol homeostasis", Science, 328, pp.1570~1573 (2010)
49. Karunakaran D, "Macrophage mitochondrial energy status regulates cholesterol efflux and is enhanced by anti-miR33 in atherosclerosis", Circ Res, 117, pp.266~278 (2015)
50. Ouimet M, "microRNA-33 regulates macrophage autophagy in atherosclerosis", Arterioscler Thromb Vasc Biol, 37, pp.1058~1067 (2017)
51. Rayner KJ, "Inhibition of miR-33a", b in non-human primates raises plasma HDL and lowers VLDL triglycerides, 2011, pp.478, 404~407
52. Zhen Z, "The lncRNA DAPK-IT1 regulates cholesterol metabolism and inflammatory response in macrophages and promotes atherogenesis", Biochem Biophys Res Commun, 516, pp.1234~1241 (2019)
53. Wang CH, "Identification of key lncRNAs associated with atherosclerosis progression based on public datasets", Front Genet, 10, pp.123~ (2019)
54. Yin Q, "Plasma long non-coding RNA(lncRNA)GAS5 is a new biomarker for coronary artery disease", Med Sci Monit, 23, pp.6042~6048 (2017)
55. Tao H, "LncRNA GAS5 controls cardiac fibroblast activation and fibrosis by targeting miR-21 via PTEN", MMP-2 signaling pathway, 2017, pp.386, 11~18
56. Ye J, "LncRBA GSA5, up-regulated by ox-LDL, aggravates inflammatory response and MMP expression in THP-1 macrophages by acting like a sponge for miR-221", Exp Cell Res, 369, pp.348~355 (2018)
57. Shen S, "Silencing of GAS5 represses the malignant progression of atherosclerosis through upregulation of miR-135a", Biomed Pharmacother, 118, pp.109302~ (2019)
58. Ye ZM, "LncRNA MIAT sponges miR-149-5p to inhibit efferocytosis in advanced atherosclerosis through CD47 upregulation", Cell Death Dis, 10, pp.138~ (2019)
59. Thorp EB, "Contrasting inflammation resolution during atherosclerosis and post myocardial infarction at the level of monocyte", macrophage phagocytic clearance, 2012, pp.3, 39~

관련 논문AI추천